Anthrax is built from a single bacterial species, Bacillus anthracis, but what makes the disease so dangerous is not just the bacterium itself. It is the combination of ultra-durable spores, a stealth capsule that hides the bacterium from immune cells, and a precise three-protein toxin system that dismantles the body’s defenses from the inside. Each of these components has a distinct molecular makeup, and understanding them helps explain why anthrax behaves so differently from most other infections.
The Bacterium and Its Spore
Bacillus anthracis is a large, rod-shaped, gram-positive bacterium that lives in soil. In favorable conditions it grows and divides like many other bacteria, but what sets it apart is what happens when nutrients run out. The bacterium forms an endospore, a dormant survival capsule that can persist in soil for decades. The spore is the form most commonly encountered in nature and in bioterror scenarios, so its composition matters.
A spore is far more than a shrunken version of the bacterium. At its center sits a core that houses a compressed copy of the chromosome, surrounded by layers that each serve a specific protective role. Moving outward from the core, there is a thick peptidoglycan layer (similar in chemistry to a bacterial cell wall) that helps maintain dormancy, then a protein shell called the coat that resists chemical attack, and finally an outer layer of proteins and glycoproteins that mediates how the spore interacts with surfaces and host tissues.1PubMed. The Bacillus anthracis spore Proteomic analysis has identified more than 750 distinct proteins within the spore, including an assortment of metabolic and protective enzymes that are not obviously related to each other but collectively allow the spore to survive extreme heat, ultraviolet radiation, and chemical disinfection.2PubMed Central. Formation and composition of the Bacillus anthracis endospore
The outermost spore surface includes a protein called BclA, which turns out to be important once the spore enters a host. Immune cells called macrophages recognize BclA through surface receptors, grab the spore, and swallow it, inadvertently carrying the spore from the site of entry deeper into the body to lymph nodes.3PubMed Central. CD14-Mac-1 interactions in Bacillus anthracis spore internalization by macrophages This is where germination begins: the spore senses the warm, nutrient-rich interior of the host, sheds its protective layers, and reverts to a growing bacterium.
Two Plasmids That Make All the Difference
B. anthracis is genetically very close to common soil bacteria like B. cereus and B. thuringiensis. The chromosomal DNA of all three species is remarkably similar.4PubMed Central. Genome differences that distinguish Bacillus anthracis from Bacillus cereus and Bacillus thuringiensis What transforms B. anthracis from a harmless dirt bacterium into a lethal pathogen are two extra rings of DNA called plasmids, and losing either one dramatically weakens the organism.
The larger plasmid, pXO1, is about 182 kilobases and carries the genes for the three toxin proteins. Within pXO1 sits a roughly 45-kilobase “pathogenicity island,” a stretch of DNA bordered by mobile genetic elements, that contains the toxin genes (cya, lef, and pagA), regulatory elements that control when those genes turn on, and germination-response genes.5PubMed Central. Sequence and organization of pXO1, the large Bacillus anthracis plasmid harboring the anthrax toxin genes The smaller plasmid, pXO2, is about 96 kilobases and carries the genes for the capsule, including the biosynthetic operon capBCAD.6PubMed Central. Capsule synthesis by Bacillus anthracis is required for dissemination in murine inhalation anthrax Strains missing pXO2 but carrying pXO1 are severely weakened in animal models, which is why some vaccine strains (like the classic Sterne strain used in livestock) lack pXO2: they still produce protective antigen to stimulate immunity but cannot form the capsule that enables full-blown disease.
Both plasmids are coordinated by a master regulator called AtxA, which activates the transcription of toxin and capsule genes when conditions inside the host signal the bacterium to switch to attack mode.7FEMS Microbiology Letters. AtxA activates the transcription of genes harbored by both Bacillus anthracis virulence plasmids Without AtxA, neither toxins nor capsule are produced in meaningful quantities, even though all the structural genes are present.
The Three-Part Toxin System
The anthrax toxin is not a single molecule. It is a toolkit of three proteins that combine in pairs to form two distinct toxins. All three proteins are individually harmless and only become dangerous when they assemble on the surface of a host cell.
- Protective antigen (PA): The shared delivery vehicle. PA binds to receptors on host cells, gets clipped by a host enzyme, and then assembles into a ring-shaped structure (a heptamer, or sometimes an octamer) that acts as a docking platform for the other two proteins.8PubMed. Anthrax toxin: receptor binding, internalization, pore formation, and translocation
- Lethal factor (LF): A metalloprotease enzyme that, once inside the cell, clips and inactivates key signaling proteins called MAP kinase kinases. This disrupts a major cell-communication pathway.9PubMed. Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor
- Edema factor (EF): An enzyme that, once it meets a host molecule called calmodulin inside the cell, becomes a powerful adenylyl cyclase, flooding the cell with cyclic AMP, a signaling molecule that at normal levels is routine but at massively elevated levels causes fluid to pour into tissues.10PubMed Central. The adenylyl cyclase activity of anthrax edema factor
PA plus LF form lethal toxin (LT). PA plus EF form edema toxin (ET). Both toxins use the same PA doorway to enter cells, but once inside they do very different kinds of damage.
How Protective Antigen Gets the Toxins Inside Cells
PA is the linchpin, and its mechanism is surprisingly elegant. After PA binds to a cell receptor and the host enzyme furin cleaves it, the activated PA fragments cluster into a ring-shaped prepore on the cell surface. LF and EF bind to exposed sites on this ring. The entire complex then gets pulled inside the cell through normal receptor-mediated uptake, ending up in a small acidic compartment called an endosome.11PubMed Central. Structure of heptameric protective antigen bound to an anthrax toxin receptor: a role for receptor in pH-dependent pore formation
As the endosome acidifies, the PA ring undergoes a dramatic shape change, converting from a flat prepore into a channel that punches through the endosomal membrane. A region called the phi-clamp forms a tight seal around the LF or EF protein as it threads through the pore, ensuring a leak-free transfer into the cell’s interior.12PubMed Central. Anthrax toxin protective antigen–insights into molecular switching from prepore to pore The receptor itself plays a regulatory role in this process: its interaction with PA raises the acid threshold needed for the prepore-to-pore switch, acting as a kind of safety catch that delays pore formation until the complex is safely inside the endosome rather than at the cell surface.
What the Toxins Do to the Body
Once lethal factor reaches the cell interior, it clips the tails off MAP kinase kinases, shutting down a signaling cascade that cells rely on for growth, stress response, and immune activation.13PubMed. The anthrax lethal factor and its MAPK kinase-specific metalloprotease activity The consequences ripple outward. In the blood vessels, lethal toxin weakens the junctions between the cells lining vessel walls. Lab studies show that lethal toxin causes a concentration-dependent breakdown in the barrier that normally keeps fluid inside blood vessels, along with visible rearrangement of the structural proteins that hold endothelial cells together.14PubMed Central. Anthrax lethal toxin induces endothelial barrier dysfunction The mechanism runs through p38 signaling: lethal toxin inactivates p38, which in turn disrupts a downstream chain that normally keeps the cell skeleton tight and the barrier sealed.15PubMed Central. Anthrax lethal toxin disrupts the endothelial permeability barrier through blocking p38 signaling
In animal models, lethal toxin also disrupts a receptor called Tie-2 that normally helps maintain blood-vessel integrity. When Tie-2 signaling was genetically boosted in mice, endothelial junctions held firm, vascular leakage dropped, and survival improved after lethal toxin challenge. Primates infected with live B. anthracis showed a rapid imbalance in the molecules that signal through Tie-2, mirroring what was seen in the mouse experiments.16PubMed Central. Impaired function of the Tie-2 receptor contributes to vascular leakage and lethality in anthrax This vascular collapse, where fluid leaks out of blood vessels into tissues, is a major reason systemic anthrax is so often fatal: organs become waterlogged and stop functioning.
Edema factor contributes a different but complementary kind of damage. By flooding cells with cyclic AMP, it disrupts fluid balance in tissues, producing the massive swelling (edema) that gives the toxin its name.17PubMed. Inhibitors of Bacillus anthracis edema factor It also suppresses certain immune-cell responses, further clearing the way for unchecked bacterial growth.
The Capsule as Immune Camouflage
The toxins get most of the attention, but the capsule is equally essential. Once B. anthracis germinates and starts growing as a vegetative bacterium, it produces a thick outer coating made of poly-gamma-D-glutamic acid (PGA). This unusual polymer is a chain of the amino acid glutamic acid linked in a configuration that mammalian immune systems do not recognize well. The capsule disguises the bacterium from immune surveillance and allows it to grow unchecked in the host.18PubMed Central. The poly-γ-D-glutamic acid capsule of Bacillus anthracis enhances lethal toxin activity Both PA and the PGA capsule are considered essential for full virulence.19PubMed Central. Poly(gamma-D-glutamic acid) protein conjugates induce IgG antibodies in mice to the capsule of Bacillus anthracis: a potential addition to the anthrax vaccine
In a gastrointestinal anthrax model, researchers found that loss of the capsule plasmid (pXO2) severely reduced virulence, even more than losing the toxin plasmid (pXO1), which only moderately reduced disease severity. Without toxins, bacterial replication slowed but the bacteria could still cause illness; without the capsule, the immune system could contain the infection much more effectively.20PubMed Central. Modeling gastrointestinal anthrax disease That finding underscores how the capsule and the toxins work as a team: the capsule provides the cover, and the toxins do the damage.
B. anthracis has another molecular trick for survival inside the host. To grow, bacteria need iron, which mammalian hosts lock away as part of their innate defense. B. anthracis produces two small iron-scavenging molecules called siderophores: bacillibactin and petrobactin. The host immune protein siderocalin can neutralize bacillibactin, but petrobactin has an unusual chemical structure that changes the shape of its iron complex enough to evade siderocalin entirely. Petrobactin plays a key role in virulence precisely because the immune system cannot intercept it.
Different Routes of Infection, Same Components
Anthrax presents in several clinical forms depending on how spores enter the body, but the underlying molecular machinery is the same in every case. Cutaneous anthrax, the most common natural form, occurs when spores enter through a break in the skin. Inhalation anthrax happens when spores are breathed deep into the lungs, carried by macrophages to the lymph nodes in the chest, and germinate there. Pathological studies of inhalation anthrax cases show that the damage pattern is consistent with spore transport to mediastinal lymph nodes, followed by local bacterial growth, systemic spread, and widespread edema and cell death driven by edema toxin and lethal toxin.21PubMed. Quantitative pathology of inhalational anthrax I: quantitative microscopic findings
Gastrointestinal anthrax results from ingesting contaminated meat. In animal models, spores germinate in the gut, the bacteria invade the intestinal lining, and dissemination follows into the spleen, liver, kidneys, and lungs. Histological examination of infected animals reveals destruction of intestinal structure, hemorrhage, edema, and bacterial invasion of multiple organs.22PLoS ONE. A New Murine Model for Gastrointestinal Anthrax Infection Regardless of the entry route, the endgame is the same: the capsule shields the bacteria, the toxins break down vascular barriers and disable immune signaling, and the disease progresses toward sepsis.
Why Spores Survive So Long in Soil
The spore’s molecular composition explains its legendary durability, but where it persists best depends on soil chemistry. Studies from multiple continents have converged on a consistent picture: anthrax spores survive longest in alkaline soils that are rich in calcium and other minerals. In a study of anthrax distribution in western Uganda, the strongest predictors of spore-friendly conditions were high potassium, high calcium, alkaline pH (at or above about 7.4), low rainfall, and warm temperatures.23PubMed Central. Environmental determinants influencing anthrax distribution in Queen Elizabeth Protected Area, Western Uganda A parallel analysis in northwest Minnesota found that soil calcium, magnesium, pH, and sand content were the variables most strongly correlated with reported anthrax cases.24Applied Geochemistry. Soil geochemical parameters influencing the spatial distribution of anthrax in Northwest Minnesota, USA
Research from anthrax-endemic areas in India confirmed that endemic sites had alkaline pH ranging from about 7.8 to 8.9, higher organic carbon, elevated phosphorus, and greater clay content, while non-endemic soils were neutral to slightly acidic with sandier texture that limits long-term spore retention.25PubMed. Molecular analysis of Bacillus anthracis isolates from Karnataka’s ruminant anthrax outbreaks reveals genetic relationships and environmental factors influencing spore persistence Alkaline, mineral-rich, clay-heavy soils essentially act as long-term storage for spores, which is why anthrax outbreaks in livestock tend to recur in the same geographic pockets for generations.
Detecting and Identifying Anthrax
Because B. anthracis is so closely related to its harmless cousins, identifying it reliably is not straightforward. Labs use the molecular components unique to anthrax, especially genes on its two plasmids, as diagnostic markers. A real-time PCR protocol developed after the 2001 U.S. mail attacks targets both a chromosomal gene (rpoB) and a plasmid gene (lef, which encodes lethal factor) to simultaneously confirm that the organism is B. anthracis and distinguish it from closely related species and vaccine strains.26PubMed Central. Protocol for real-time PCR identification of anthrax spores from nasal swabs after broth enrichment
For suspicious powders, a mass spectrometry approach (MALDI-TOF MS) was developed and validated against reference libraries of Bacillus species and common hoax materials like baking soda and flour. The method could detect a minimum of about 2.5 million spores, equivalent to roughly 55 micrograms of the crudest anthrax-containing powder discovered during the 2001 incidents, with no false positives or false negatives across a wide range of bacterial and non-bacterial samples.27PubMed Central. Rapid identification of Bacillus anthracis spores in suspicious powder samples by using matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) Newer proteomic methods are pushing toward even more targeted detection by identifying unique spore-surface protein markers that can distinguish B. anthracis spores within complex environmental samples.28Molecular & Cellular Proteomics. Comparative Proteomic Analysis of Bacillus anthracis Spores: Toward the Identification of Unique Protein Markers for Improved Spore Detection
Medical Countermeasures Built Around Toxin Components
Knowing what anthrax is made of has directly shaped how we fight it. Nearly every major medical countermeasure targets one of the molecular components described above.
Vaccines, both the currently licensed ones and next-generation candidates, center on protective antigen. Because PA is the shared delivery vehicle for both lethal factor and edema factor, antibodies that block PA prevent both toxins from entering cells. Recombinant PA-based vaccines have shown a good safety and protective profile in preclinical and clinical studies.29PubMed. Vaccines against anthrax based on recombinant protective antigen: problems and solutions Some experimental veterinary vaccines have gone further, combining recombinant PA with inactivated versions of LF and EF to stimulate broader immune responses; animals vaccinated with these trivalent formulations produced antibodies against all three toxin components that persisted for at least six months.30PubMed. Protective activity and immunogenicity of two recombinant anthrax vaccines for veterinary use
For treatment of active infection, monoclonal antibodies that target PA are now approved or in advanced development. Obiltoxaximab, a monoclonal antibody against PA, is approved for treating inhalation anthrax in combination with antibiotics and for prophylaxis when alternatives are unavailable.31PubMed Central. Obiltoxaximab Prevents Disseminated Bacillus anthracis Infection and Improves Survival during Pre- and Postexposure Prophylaxis in Animal Models of Inhalational Anthrax In rabbit studies, a single dose dramatically improved survival compared to placebo, with rates reaching above 90% at the standard dose in some studies.32PubMed Central. Efficacy Projection of Obiltoxaximab for Treatment of Inhalational Anthrax across a Range of Disease Severity Raxibacumab, another fully human monoclonal antibody, works the same way: it blocks PA from binding to its receptor on host cells, preventing the toxin from ever getting inside.33PubMed. Pharmacology and Anti-infective Role of Raxibacumab: A Novel Monoclonal Antibody for the Treatment of Anthrax
Researchers are also developing small-molecule drugs that target the enzymatic components directly. Small-molecule inhibitors of lethal factor’s protease activity have shown the ability to protect mice from lethal anthrax infection, both in combination with antibiotics and as a standalone treatment.34PubMed Central. Small-molecule inhibitors of lethal factor protease activity protect against anthrax infection On the edema factor side, drug-like molecules derived from a chemical probe have achieved up to a thousand-fold improvement in potency against EF’s enzymatic activity compared to the original probe, with low cross-reactivity against unrelated human enzymes.35PubMed Central. Small molecule inhibitors of anthrax edema factor These are still experimental, but they illustrate how detailed knowledge of what anthrax toxins are made of opens specific therapeutic targets that antibiotics alone cannot address. Antibiotics kill the bacteria but do nothing about toxin molecules already circulating in the bloodstream; antitoxin therapies aim to fill that gap.
Why B. anthracis Is So Close to Harmless Relatives
One of the more unsettling facts about anthrax is how little separates it genetically from bacteria you encounter in everyday life. B. anthracis, B. cereus (a common cause of food poisoning), and B. thuringiensis (widely used as a biological insecticide) are so closely related that some taxonomists have argued they should be considered a single species. All three inhabit soil. Genomic comparison shows that B. anthracis is remarkably uniform from strain to strain, while its relatives are genetically diverse.4PubMed Central. Genome differences that distinguish Bacillus anthracis from Bacillus cereus and Bacillus thuringiensis That low diversity in B. anthracis suggests the species emerged relatively recently from the broader B. cereus group, acquiring the two critical plasmids and a small number of chromosomal changes that together created a pathogen capable of causing lethal systemic disease. The plasmids are portable rings of DNA, and lab experiments have shown that transferring them into B. cereus strains can make those strains cause anthrax-like disease in animals. In other words, “what anthrax is made of” boils down to a common soil bacterium plus two acquired genetic packages carrying the instructions for a capsule and a toxin system. The rest of the organism is, for all practical purposes, borrowed from a lineage of harmless dirt microbes.